Five new manufacturer restrictions on wholly-owned pharmacies taking effect in July will be “disastrous” for certain health center pharmacy arrangements, [...] …
Year: 2024
Two community health centers urged a federal appeals court to reverse an earlier dismissal of their lawsuit alleging four major [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The California Hospital Association (CHA) is the latest organization to raise concerns about the 340B ACCESS Act, a bill recently [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Q: Where did you grow up?
Slinger, Wisconsin. It’s a small town north of Milwaukee. If you’ve heard of it, it’s probably either because of Little Switzerland (small ski hill) or the Slinger Super Speedway (racetrack).
Q: Where did you go to college/graduate school?
I’m a Badger through and through – I went to undergraduate and Pharmacy School
…
SPONSORED CONTENT
TIP: Enhance your 340B program efficiency through collaborative review and impact analysis.
Asking your TPA
A prominent West Virginia Republican is considering taking legal action after a political action committee (PAC) reportedly spent $400,000-plus against [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Inflation Reduction Act (IRA) may reduce 340B margins for certain high-cost drugs and drive more transparency into the program, an influential pharmaceutical supply chain analyst who has been a frequent 340B critic told an audience of stakeholders late last
…
A bill that would enact contract pharmacy protections in Michigan has garnered renewed attention from 340B supporters and critics, alike, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A powerful brand-name drug industry trade organization has asked a federal district judge to block Maryland from enforcing the state’s [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical giant Eli Lilly has significantly escalated its restrictions on access to 340B pricing in the contract pharmacy setting, the [...] …
